NeuroPace, the maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, announced a $33 million equity raise on Monday. Accelmed Partners led the investment, which ...

Evening, I'm Carol Clark, and news for your health diabetic neuropathy. Nearly half of those who deal with diabetes also deal with the problem of nerve pain, numbness, tingling, or burning in their ...

Peter L. Salgo, MD: Let’s go a bit more off the reservation. We’ve got the gammaCore neurostimulation device. What is that? Peter Goadsby, MD, PhD: GammaCore is a noninvasive vagus nerve stimulator.

For many people living with multiple sclerosis (MS), walking can become one of the most challenging daily tasks. As many as 3 in 4 people with MS have gait issues caused by factors like loss of muscle ...

NeuroPace, maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, filed SEC documents yesterday outlining plans to raise as much as $75 million in an IPO listing on ...

Please provide your email address to receive an email when new articles are posted on . Artificial tears have long been the first option for patients with dry eye disease, but they only offer a ...

Add Yahoo as a preferred source to see more of our stories on Google. At-home neurostimulation devices claim to lessen the symptoms of anxiety and chronic pain (Pulsetto) For most, the idea that you ...

Restorative neurostimulation may improve pain, disability, and quality of life in chronic low back pain. Read more.

Depression is a growing problem in Canada and elsewhere, and one of the most important public health issues today, says the World Health Organization (WHO). The COVID-19 pandemic and the ensuing ...

We recently had the opportunity to chat about pain psychology, her work in reducing chronic pain, and the future of personalized medicine and where pain psychology fits in. I hope you find that her ...